Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Materials
Create a narrative
Tatva Chintan Pharma Chem
NSEI:TATVA Community
1
Narratives
written by author
0
Comments
on narratives written by author
3
Fair Values set
on narratives written by author
Create a narrative
Tatva Chintan Pharma Chem
Popular
Undervalued
Overvalued
Tatva Chintan Pharma Chem
WA
Analyst Price Target
Consensus Narrative from 4 Analysts
Commercialization Of New Products And Infrastructure Expansion Will Boost Future Outlook
Key Takeaways New product commercialization and infrastructure expansion are set to drive significant future revenue growth and operational efficiencies. Strategic customer acquisitions and increased demand in energy storage and agro segments are expected to boost revenue and earnings.
View narrative
₹1.12k
FV
43.3% undervalued
intrinsic discount
26.63%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
TATVA
Tatva Chintan Pharma Chem
Your Fair Value
₹
Current Price
₹637.00
41.8% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
12b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹11.6b
Earnings ₹445.9m
Advanced
Set as Fair Value